These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

439 related items for PubMed ID: 19195631

  • 1. The farnesoid X receptor (FXR) as a new target in non-alcoholic steatohepatitis.
    Cariou B.
    Diabetes Metab; 2008 Dec; 34(6 Pt 2):685-91. PubMed ID: 19195631
    [Abstract] [Full Text] [Related]

  • 2. FXR, a multipurpose nuclear receptor.
    Lee FY, Lee H, Hubbert ML, Edwards PA, Zhang Y.
    Trends Biochem Sci; 2006 Oct; 31(10):572-80. PubMed ID: 16908160
    [Abstract] [Full Text] [Related]

  • 3. Targeting farnesoid X receptor for liver and metabolic disorders.
    Fiorucci S, Rizzo G, Donini A, Distrutti E, Santucci L.
    Trends Mol Med; 2007 Jul; 13(7):298-309. PubMed ID: 17588816
    [Abstract] [Full Text] [Related]

  • 4. The role of FXR in disorders of bile acid homeostasis.
    Eloranta JJ, Kullak-Ublick GA.
    Physiology (Bethesda); 2008 Oct; 23():286-95. PubMed ID: 18927204
    [Abstract] [Full Text] [Related]

  • 5. Farnesoid X receptor modulates renal lipid metabolism, fibrosis, and diabetic nephropathy.
    Jiang T, Wang XX, Scherzer P, Wilson P, Tallman J, Takahashi H, Li J, Iwahashi M, Sutherland E, Arend L, Levi M.
    Diabetes; 2007 Oct; 56(10):2485-93. PubMed ID: 17660268
    [Abstract] [Full Text] [Related]

  • 6. Role of bile acids and bile acid receptors in metabolic regulation.
    Lefebvre P, Cariou B, Lien F, Kuipers F, Staels B.
    Physiol Rev; 2009 Jan; 89(1):147-91. PubMed ID: 19126757
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The Farnesoid X receptor: a molecular link between bile acid and lipid and glucose metabolism.
    Claudel T, Staels B, Kuipers F.
    Arterioscler Thromb Vasc Biol; 2005 Oct; 25(10):2020-30. PubMed ID: 16037564
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Bile acid retention and activation of endogenous hepatic farnesoid-X-receptor in the pathogenesis of fatty liver disease in ob/ob-mice.
    Martin IV, Schmitt J, Minkenberg A, Mertens JC, Stieger B, Mullhaupt B, Geier A.
    Biol Chem; 2010 Dec; 391(12):1441-9. PubMed ID: 20868235
    [Abstract] [Full Text] [Related]

  • 16. Suppression of interleukin-6-induced C-reactive protein expression by FXR agonists.
    Zhang S, Liu Q, Wang J, Harnish DC.
    Biochem Biophys Res Commun; 2009 Feb 06; 379(2):476-9. PubMed ID: 19118524
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Potential regulatory role of the farnesoid X receptor in the metabolic syndrome.
    Duran-Sandoval D, Cariou B, Fruchart JC, Staels B.
    Biochimie; 2005 Jan 06; 87(1):93-8. PubMed ID: 15733743
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.